Menlo Therapeutics Profit Margin

The latest profit margin for MNLO is -1519.63% as of September 2020. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Menlo Therapeutics's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, MNLO currently prints -1519.63% for profit margin, while the sector average sits near 15.58%. That is roughly 9851.2% below the sector mean. Large gaps often invite a closer look at Menlo Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Menlo Therapeutics converts resources into returns. At -1519.63%, MNLO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MNLO's profit margin (-1519.63%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Menlo Therapeutics's profit margin against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.